Click for best price
RNA Interference RNAi Drug Delivery Market Size, Share 2022
This report contains market size and forecasts of RNA Interference (RNAi) Drug Delivery in global, including the following market information:
Global RNA Interference (RNAi) Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global RNA Interference (RNAi) Drug Delivery Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five RNA Interference (RNAi) Drug Delivery companies in 2021 (%)
The global RNA Interference (RNAi) Drug Delivery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nanoparticle Drug Delivery Technology Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of RNA Interference (RNAi) Drug Delivery include Metabolic disorders, Alnylam Pharmaceuticals Inc, Merck & Co. Inc, Access Pharmaceuticals Inc, Dicerna Pharmaceuticals Inc, Calondo Pharmaceuticals Inc, Marina Biotech Inc, RXi Pharmaceuticals Corp and Quark Pharmaceuticals Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the RNA Interference (RNAi) Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNA Interference (RNAi) Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global RNA Interference (RNAi) Drug Delivery Market Segment Percentages, by Type, 2021 (%)
Nanoparticle Drug Delivery Technology
Pulmonary Drug Delivery Technology
Nucleic Acid Drug Delivery Technology
Aptamer Drug Delivery Technology
Global RNA Interference (RNAi) Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global RNA Interference (RNAi) Drug Delivery Market Segment Percentages, by Application, 2021 (%)
Infectious Diseases
Cardiology
Oncology
Neurology
Ophthalmology
Metabolic Disorders
Global RNA Interference (RNAi) Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global RNA Interference (RNAi) Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNA Interference (RNAi) Drug Delivery revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies RNA Interference (RNAi) Drug Delivery revenues share in global market, 2021 (%)
Key companies RNA Interference (RNAi) Drug Delivery sales in global market, 2017-2022 (Estimated), (K Units)
Key companies RNA Interference (RNAi) Drug Delivery sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Metabolic disorders
Alnylam Pharmaceuticals Inc
Merck & Co. Inc
Access Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc
Calondo Pharmaceuticals Inc
Marina Biotech Inc
RXi Pharmaceuticals Corp
Quark Pharmaceuticals Inc
Silence Therapeutics plc
Tacere Therapeutics Inc
PhaseRx Inc
Sirnaomics Inc
Traversa Therapeutics Inc
| Report Attributes |
Report Details |
| Report Title |
RNA Interference (RNAi) Drug Delivery Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
71 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 RNA Interference (RNAi) Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNA Interference (RNAi) Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNA Interference (RNAi) Drug Delivery Overall Market Size
2.1 Global RNA Interference (RNAi) Drug Delivery Market Size: 2021 VS 2028
2.2 Global RNA Interference (RNAi) Drug Delivery Revenue, Prospects & Forecasts: 2017-2028
2.3 Global RNA Interference (RNAi) Drug Delivery Sales: 2017-2028
3 Company Landscape
3.1 Top RNA Interference (RNAi) Drug Delivery Players in Global Market
3.2 Top Global RNA Interference (RNAi) Drug Delivery Companies Ranked by Revenue
3.3 Global RNA Interference (RNAi) Drug Delivery Revenue by Companies
3.4 Global RNA Interference (RNAi) Drug Delivery Sales by Companies
3.5 Global RNA Interference (RNAi) Drug Delivery Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 RNA Interference (RNAi) Drug Delivery Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers RNA Interference (RNAi) Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 RNA Interference (RNAi) Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 RNA Interference (RNAi) Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 RNA Interference (RNAi) Drug Delivery Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global RNA Interference (RNAi) Drug Delivery Market Size Markets, 2021 & 2028
4.1.2 Nanoparticle Drug Delivery Technology
4.1.3 Pulmonary Drug Delivery Technology
4.1.4 Nucleic Acid Drug Delivery Technology
4.1.5 Aptamer Drug Delivery Technology
4.2 By Type - Global RNA Interference (RNAi) Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global RNA Interference (RNAi) Drug Delivery Revenue, 2017-2022
4.2.2 By Type - Global RNA Interference (RNAi) Drug Delivery Revenue, 2023-2028
4.2.3 By Type - Global RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2017-2028
4.3 By Type - Global RNA Interference (RNAi) Drug Delivery Sales & Forecasts
4.3.1 By Type - Global RNA Interference (RNAi) Drug Delivery Sales, 2017-2022
4.3.2 By Type - Global RNA Interference (RNAi) Drug Delivery Sales, 2023-2028
4.3.3 By Type - Global RNA Interference (RNAi) Drug Delivery Sales Market Share, 2017-2028
4.4 By Type - Global RNA Interference (RNAi) Drug Delivery Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global RNA Interference (RNAi) Drug Delivery Market Size, 2021 & 2028
5.1.2 Infectious Diseases
5.1.3 Cardiology
5.1.4 Oncology
5.1.5 Neurology
5.1.6 Ophthalmology
5.1.7 Metabolic Disorders
5.2 By Application - Global RNA Interference (RNAi) Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global RNA Interference (RNAi) Drug Delivery Revenue, 2017-2022
5.2.2 By Application - Global RNA Interference (RNAi) Drug Delivery Revenue, 2023-2028
5.2.3 By Application - Global RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2017-2028
5.3 By Application - Global RNA Interference (RNAi) Drug Delivery Sales & Forecasts
5.3.1 By Application - Global RNA Interference (RNAi) Drug Delivery Sales, 2017-2022
5.3.2 By Application - Global RNA Interference (RNAi) Drug Delivery Sales, 2023-2028
5.3.3 By Application - Global RNA Interference (RNAi) Drug Delivery Sales Market Share, 2017-2028
5.4 By Application - Global RNA Interference (RNAi) Drug Delivery Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global RNA Interference (RNAi) Drug Delivery Market Size, 2021 & 2028
6.2 By Region - Global RNA Interference (RNAi) Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global RNA Interference (RNAi) Drug Delivery Revenue, 2017-2022
6.2.2 By Region - Global RNA Interference (RNAi) Drug Delivery Revenue, 2023-2028
6.2.3 By Region - Global RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2017-2028
6.3 By Region - Global RNA Interference (RNAi) Drug Delivery Sales & Forecasts
6.3.1 By Region - Global RNA Interference (RNAi) Drug Delivery Sales, 2017-2022
6.3.2 By Region - Global RNA Interference (RNAi) Drug Delivery Sales, 2023-2028
6.3.3 By Region - Global RNA Interference (RNAi) Drug Delivery Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America RNA Interference (RNAi) Drug Delivery Revenue, 2017-2028
6.4.2 By Country - North America RNA Interference (RNAi) Drug Delivery Sales, 2017-2028
6.4.3 US RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.4.4 Canada RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.4.5 Mexico RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe RNA Interference (RNAi) Drug Delivery Revenue, 2017-2028
6.5.2 By Country - Europe RNA Interference (RNAi) Drug Delivery Sales, 2017-2028
6.5.3 Germany RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.5.4 France RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.5.5 U.K. RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.5.6 Italy RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.5.7 Russia RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.5.8 Nordic Countries RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.5.9 Benelux RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia RNA Interference (RNAi) Drug Delivery Revenue, 2017-2028
6.6.2 By Region - Asia RNA Interference (RNAi) Drug Delivery Sales, 2017-2028
6.6.3 China RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.6.4 Japan RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.6.5 South Korea RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.6.6 Southeast Asia RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.6.7 India RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America RNA Interference (RNAi) Drug Delivery Revenue, 2017-2028
6.7.2 By Country - South America RNA Interference (RNAi) Drug Delivery Sales, 2017-2028
6.7.3 Brazil RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.7.4 Argentina RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa RNA Interference (RNAi) Drug Delivery Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales, 2017-2028
6.8.3 Turkey RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.8.4 Israel RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.8.5 Saudi Arabia RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
6.8.6 UAE RNA Interference (RNAi) Drug Delivery Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Metabolic disorders
7.1.1 Metabolic disorders Corporate Summary
7.1.2 Metabolic disorders Business Overview
7.1.3 Metabolic disorders RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.1.4 Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2017-2022)
7.1.5 Metabolic disorders Key News
7.2 Alnylam Pharmaceuticals Inc
7.2.1 Alnylam Pharmaceuticals Inc Corporate Summary
7.2.2 Alnylam Pharmaceuticals Inc Business Overview
7.2.3 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.2.4 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2017-2022)
7.2.5 Alnylam Pharmaceuticals Inc Key News
7.3 Merck & Co. Inc
7.3.1 Merck & Co. Inc Corporate Summary
7.3.2 Merck & Co. Inc Business Overview
7.3.3 Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.3.4 Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2017-2022)
7.3.5 Merck & Co. Inc Key News
7.4 Access Pharmaceuticals Inc
7.4.1 Access Pharmaceuticals Inc Corporate Summary
7.4.2 Access Pharmaceuticals Inc Business Overview
7.4.3 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.4.4 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2017-2022)
7.4.5 Access Pharmaceuticals Inc Key News
7.5 Dicerna Pharmaceuticals Inc
7.5.1 Dicerna Pharmaceuticals Inc Corporate Summary
7.5.2 Dicerna Pharmaceuticals Inc Business Overview
7.5.3 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.5.4 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2017-2022)
7.5.5 Dicerna Pharmaceuticals Inc Key News
7.6 Calondo Pharmaceuticals Inc
7.6.1 Calondo Pharmaceuticals Inc Corporate Summary
7.6.2 Calondo Pharmaceuticals Inc Business Overview
7.6.3 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.6.4 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2017-2022)
7.6.5 Calondo Pharmaceuticals Inc Key News
7.7 Marina Biotech Inc
7.7.1 Marina Biotech Inc Corporate Summary
7.7.2 Marina Biotech Inc Business Overview
7.7.3 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.7.4 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2017-2022)
7.7.5 Marina Biotech Inc Key News
7.8 RXi Pharmaceuticals Corp
7.8.1 RXi Pharmaceuticals Corp Corporate Summary
7.8.2 RXi Pharmaceuticals Corp Business Overview
7.8.3 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.8.4 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2017-2022)
7.8.5 RXi Pharmaceuticals Corp Key News
7.9 Quark Pharmaceuticals Inc
7.9.1 Quark Pharmaceuticals Inc Corporate Summary
7.9.2 Quark Pharmaceuticals Inc Business Overview
7.9.3 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.9.4 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2017-2022)
7.9.5 Quark Pharmaceuticals Inc Key News
7.10 Silence Therapeutics plc
7.10.1 Silence Therapeutics plc Corporate Summary
7.10.2 Silence Therapeutics plc Business Overview
7.10.3 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.10.4 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2017-2022)
7.10.5 Silence Therapeutics plc Key News
7.11 Tacere Therapeutics Inc
7.11.1 Tacere Therapeutics Inc Corporate Summary
7.11.2 Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Business Overview
7.11.3 Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.11.4 Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2017-2022)
7.11.5 Tacere Therapeutics Inc Key News
7.12 PhaseRx Inc
7.12.1 PhaseRx Inc Corporate Summary
7.12.2 PhaseRx Inc RNA Interference (RNAi) Drug Delivery Business Overview
7.12.3 PhaseRx Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.12.4 PhaseRx Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2017-2022)
7.12.5 PhaseRx Inc Key News
7.13 Sirnaomics Inc
7.13.1 Sirnaomics Inc Corporate Summary
7.13.2 Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Business Overview
7.13.3 Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.13.4 Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2017-2022)
7.13.5 Sirnaomics Inc Key News
7.14 Traversa Therapeutics Inc
7.14.1 Traversa Therapeutics Inc Corporate Summary
7.14.2 Traversa Therapeutics Inc Business Overview
7.14.3 Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Major Product Offerings
7.14.4 Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales and Revenue in Global (2017-2022)
7.14.5 Traversa Therapeutics Inc Key News
8 Global RNA Interference (RNAi) Drug Delivery Production Capacity, Analysis
8.1 Global RNA Interference (RNAi) Drug Delivery Production Capacity, 2017-2028
8.2 RNA Interference (RNAi) Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global RNA Interference (RNAi) Drug Delivery Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 RNA Interference (RNAi) Drug Delivery Supply Chain Analysis
10.1 RNA Interference (RNAi) Drug Delivery Industry Value Chain
10.2 RNA Interference (RNAi) Drug Delivery Upstream Market
10.3 RNA Interference (RNAi) Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 RNA Interference (RNAi) Drug Delivery Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of RNA Interference (RNAi) Drug Delivery in Global Market
Table 2. Top RNA Interference (RNAi) Drug Delivery Players in Global Market, Ranking by Revenue (2021)
Table 3. Global RNA Interference (RNAi) Drug Delivery Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global RNA Interference (RNAi) Drug Delivery Revenue Share by Companies, 2017-2022
Table 5. Global RNA Interference (RNAi) Drug Delivery Sales by Companies, (K Units), 2017-2022
Table 6. Global RNA Interference (RNAi) Drug Delivery Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers RNA Interference (RNAi) Drug Delivery Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers RNA Interference (RNAi) Drug Delivery Product Type
Table 9. List of Global Tier 1 RNA Interference (RNAi) Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNA Interference (RNAi) Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global RNA Interference (RNAi) Drug Delivery Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global RNA Interference (RNAi) Drug Delivery Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global RNA Interference (RNAi) Drug Delivery Sales (K Units), 2017-2022
Table 15. By Type - Global RNA Interference (RNAi) Drug Delivery Sales (K Units), 2023-2028
Table 16. By Application ? Global RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global RNA Interference (RNAi) Drug Delivery Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global RNA Interference (RNAi) Drug Delivery Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global RNA Interference (RNAi) Drug Delivery Sales (K Units), 2017-2022
Table 20. By Application - Global RNA Interference (RNAi) Drug Delivery Sales (K Units), 2023-2028
Table 21. By Region ? Global RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global RNA Interference (RNAi) Drug Delivery Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global RNA Interference (RNAi) Drug Delivery Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global RNA Interference (RNAi) Drug Delivery Sales (K Units), 2017-2022
Table 25. By Region - Global RNA Interference (RNAi) Drug Delivery Sales (K Units), 2023-2028
Table 26. By Country - North America RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2017-2022
Table 29. By Country - North America RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2023-2028
Table 30. By Country - Europe RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2017-2022
Table 33. By Country - Europe RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2023-2028
Table 34. By Region - Asia RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2017-2022
Table 37. By Region - Asia RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2023-2028
Table 38. By Country - South America RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2017-2022
Table 41. By Country - South America RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales, (K Units), 2023-2028
Table 46. Metabolic disorders Corporate Summary
Table 47. Metabolic disorders RNA Interference (RNAi) Drug Delivery Product Offerings
Table 48. Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Alnylam Pharmaceuticals Inc Corporate Summary
Table 50. Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 51. Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Merck & Co. Inc Corporate Summary
Table 53. Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 54. Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Access Pharmaceuticals Inc Corporate Summary
Table 56. Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 57. Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Dicerna Pharmaceuticals Inc Corporate Summary
Table 59. Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 60. Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Calondo Pharmaceuticals Inc Corporate Summary
Table 62. Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 63. Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Marina Biotech Inc Corporate Summary
Table 65. Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 66. Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. RXi Pharmaceuticals Corp Corporate Summary
Table 68. RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Product Offerings
Table 69. RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Quark Pharmaceuticals Inc Corporate Summary
Table 71. Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 72. Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Silence Therapeutics plc Corporate Summary
Table 74. Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 75. Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Tacere Therapeutics Inc Corporate Summary
Table 77. Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 78. Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. PhaseRx Inc Corporate Summary
Table 80. PhaseRx Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 81. PhaseRx Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Sirnaomics Inc Corporate Summary
Table 83. Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 84. Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Traversa Therapeutics Inc Corporate Summary
Table 86. Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Product Offerings
Table 87. Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. RNA Interference (RNAi) Drug Delivery Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 89. Global RNA Interference (RNAi) Drug Delivery Capacity Market Share of Key Manufacturers, 2020-2022
Table 90. Global RNA Interference (RNAi) Drug Delivery Production by Region, 2017-2022 (K Units)
Table 91. Global RNA Interference (RNAi) Drug Delivery Production by Region, 2023-2028 (K Units)
Table 92. RNA Interference (RNAi) Drug Delivery Market Opportunities & Trends in Global Market
Table 93. RNA Interference (RNAi) Drug Delivery Market Drivers in Global Market
Table 94. RNA Interference (RNAi) Drug Delivery Market Restraints in Global Market
Table 95. RNA Interference (RNAi) Drug Delivery Raw Materials
Table 96. RNA Interference (RNAi) Drug Delivery Raw Materials Suppliers in Global Market
Table 97. Typical RNA Interference (RNAi) Drug Delivery Downstream
Table 98. RNA Interference (RNAi) Drug Delivery Downstream Clients in Global Market
Table 99. RNA Interference (RNAi) Drug Delivery Distributors and Sales Agents in Global Market
List of Figures
Figure 1. RNA Interference (RNAi) Drug Delivery Segment by Type
Figure 2. RNA Interference (RNAi) Drug Delivery Segment by Application
Figure 3. Global RNA Interference (RNAi) Drug Delivery Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global RNA Interference (RNAi) Drug Delivery Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global RNA Interference (RNAi) Drug Delivery Revenue, 2017-2028 (US$, Mn)
Figure 7. RNA Interference (RNAi) Drug Delivery Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by RNA Interference (RNAi) Drug Delivery Revenue in 2021
Figure 9. By Type - Global RNA Interference (RNAi) Drug Delivery Sales Market Share, 2017-2028
Figure 10. By Type - Global RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2017-2028
Figure 11. By Type - Global RNA Interference (RNAi) Drug Delivery Price (USD/Unit), 2017-2028
Figure 12. By Application - Global RNA Interference (RNAi) Drug Delivery Sales Market Share, 2017-2028
Figure 13. By Application - Global RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2017-2028
Figure 14. By Application - Global RNA Interference (RNAi) Drug Delivery Price (USD/Unit), 2017-2028
Figure 15. By Region - Global RNA Interference (RNAi) Drug Delivery Sales Market Share, 2017-2028
Figure 16. By Region - Global RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2017-2028
Figure 17. By Country - North America RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2017-2028
Figure 18. By Country - North America RNA Interference (RNAi) Drug Delivery Sales Market Share, 2017-2028
Figure 19. US RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 20. Canada RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2017-2028
Figure 23. By Country - Europe RNA Interference (RNAi) Drug Delivery Sales Market Share, 2017-2028
Figure 24. Germany RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 25. France RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 27. Italy RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 28. Russia RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2017-2028
Figure 32. By Region - Asia RNA Interference (RNAi) Drug Delivery Sales Market Share, 2017-2028
Figure 33. China RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 34. Japan RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 37. India RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2017-2028
Figure 39. By Country - South America RNA Interference (RNAi) Drug Delivery Sales Market Share, 2017-2028
Figure 40. Brazil RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa RNA Interference (RNAi) Drug Delivery Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales Market Share, 2017-2028
Figure 44. Turkey RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 45. Israel RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 47. UAE RNA Interference (RNAi) Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 48. Global RNA Interference (RNAi) Drug Delivery Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production RNA Interference (RNAi) Drug Delivery by Region, 2021 VS 2028
Figure 50. RNA Interference (RNAi) Drug Delivery Industry Value Chain
Figure 51. Marketing Channels
